Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In this report, the Asia-Pacific Stem Cells Market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Stem cells are those cells that have the ability to multiply into many different cells from muscles to brain cells. They are also capable of repairing damaged cells and they are derived from two main cells embryonic stem cells and adult stem cells. Hematopoietic stem cells are an only stem cell that is used to treat various disease and this stem cell is mainly found in the bone marrow. Stem cells are used in a medical procedure such as bone marrow transplant which is basically performed on cancer patients. The stem is also used to treat a medical condition such as Fanconi anemia, a blood disorder that causes failure of bone marrows.
The growing regenerative medicine field coupled with the rising cases of cancer around the globe is predominantly fueling the market growth of stem cells. According to the Janssen Asia Pacific, Asia Pacific hosts 50 percent of the world’s new cancer cases each year, and deaths caused by cancer in Asia are expected to increase by 36 percent by 2030. The Asia Pacific has the world’s highest incidence of liver and stomach cancers, and prostate cancer is now one of the leading male cancers in some Asian countries. Moreover, the growing launches of innovation in stem cell therapy is further anticipated to foster the market growth of stem cells. For instance, in March 2018, WideCells Group PLC has signed a deal to bring its stem cell insurance product, CellPlan, to the Asian market.
On the other hand, ethical concern associated with stem cell research is expected to restrict the market growth of stem cells.
Key Developments:
- In October 2015, Stem cell firm Stempeutics Research announced the launch of its innovative stem cell medical device 'Stempeutron' in India
- In March 2019, CALECIM® partnered with Menarini Asia-Pacific to expand the reach of its stem cell skincare products in the region. The partnership cover sales and marketing of CALECIM® products to six of the largest skin care markets in the region: China, Hong Kong, Thailand, Malaysia, Philippines, and Indonesia.
- In February 2020, Catalent, Inc. a provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, and MaSTherCell Global, Inc., a technology-focused cell and gene therapy contract development and manufacturing organization to leading cell therapy innovators, announced that Catalent has agreed to acquire MaSTherCell Global, for an aggregate of $315 million in cash, subject to a customary adjustments.
- In January 2015, The UK Medical Research Council (MRC) and the National Natural Science Foundation of China (NSFC) have announced five new joint funding awards aimed at addressing key knowledge gaps in stem cell research.
Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Stem Cells for these regions, from 2014 to 2025 (forecast), including
➜ China
➜ Japan
➜ South Korea
➜ Taiwan
➜ India
➜ Southeast Asia
➜ Australia
Asia-Pacific Stem Cells market competition by top manufacturers/players, with Stem Cells sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
➜ CCBC
➜ Vcanbio
➜ Boyalife
➜ Beikebiotech
...
On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
➜ Umbilical Cord Blood Stem Cell
➜ Embryonic Stem Cell
➜ Adult Stem Cell
➜ Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Stem Cells for each application, including
➜ Diseases Therapy
➜ Healthcare
[NOTE: If you have any special requirements, please let us know and we will offer you the report as you want.]
Table of Contents
Asia-Pacific Stem Cells Market Report 2019
1 Stem Cells Overview
1.1 Product Overview and Scope of Stem Cells
1.2 Classification of Stem Cells by Product Category
1.2.1 Asia-Pacific Stem Cells Market Size (Sales) Comparison by Types (2014-2025)
1.2.2 Asia-Pacific Stem Cells Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Umbilical Cord Blood Stem Cell
1.2.4 Embryonic Stem Cell
1.2.5 Adult Stem Cell
1.2.6 Other
1.3 Asia-Pacific Stem Cells Market by Application/End Users
1.3.1 Asia-Pacific Stem Cells Sales (Volume) and Market Share Comparison by Applications (2014-2025)
1.3.2 Diseases Therapy
1.3.3 Healthcare
1.4 Asia-Pacific Stem Cells Market by Region
1.4.1 Asia-Pacific Stem Cells Market Size (Value) Comparison by Region (2014-2025)
1.4.2 China Status and Prospect (2014-2025)
1.4.3 Japan Status and Prospect (2014-2025)
1.4.4 South Korea Status and Prospect (2014-2025)
1.4.5 Taiwan Status and Prospect (2014-2025)
1.4.6 India Status and Prospect (2014-2025)
1.4.7 Southeast Asia Status and Prospect (2014-2025)
1.4.8 Australia Status and Prospect (2014-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Stem Cells (2014-2025)
1.5.1 Asia-Pacific Stem Cells Sales and Growth Rate (2014-2025)
1.5.2 Asia-Pacific Stem Cells Revenue and Growth Rate (2014-2025)
2 Asia-Pacific Stem Cells Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Stem Cells Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Stem Cells Sales Volume and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Asia-Pacific Stem Cells Revenue and Share by Players/Suppliers (2014-2019)
2.2 Asia-Pacific Stem Cells (Volume and Value) by Type
2.2.1 Asia-Pacific Stem Cells Sales and Market Share by Type (2014-2019)
2.2.2 Asia-Pacific Stem Cells Revenue and Market Share by Type (2014-2019)
2.3 Asia-Pacific Stem Cells (Volume) by Application
2.4 Asia-Pacific Stem Cells (Volume and Value) by Region
2.4.1 Asia-Pacific Stem Cells Sales and Market Share by Region (2014-2019)
2.4.2 Asia-Pacific Stem Cells Revenue and Market Share by Region (2014-2019)
3 China Stem Cells (Volume, Value and Sales Price)
3.1 China Stem Cells Sales and Value (2014-2019)
3.1.1 China Stem Cells Sales Volume and Growth Rate (2014-2019)
3.1.2 China Stem Cells Revenue and Growth Rate (2014-2019)
3.1.3 China Stem Cells Sales Price Trend (2014-2019)
3.2 China Stem Cells Sales Volume and Market Share by Type
3.3 China Stem Cells Sales Volume and Market Share by Application
4 Japan Stem Cells (Volume, Value and Sales Price)
4.1 Japan Stem Cells Sales and Value (2014-2019)
4.1.1 Japan Stem Cells Sales Volume and Growth Rate (2014-2019)
4.1.2 Japan Stem Cells Revenue and Growth Rate (2014-2019)
4.1.3 Japan Stem Cells Sales Price Trend (2014-2019)
4.2 Japan Stem Cells Sales Volume and Market Share by Type
4.3 Japan Stem Cells Sales Volume and Market Share by Application
5 South Korea Stem Cells (Volume, Value and Sales Price)
5.1 South Korea Stem Cells Sales and Value (2014-2019)
5.1.1 South Korea Stem Cells Sales Volume and Growth Rate (2014-2019)
5.1.2 South Korea Stem Cells Revenue and Growth Rate (2014-2019)
5.1.3 South Korea Stem Cells Sales Price Trend (2014-2019)
5.2 South Korea Stem Cells Sales Volume and Market Share by Type
5.3 South Korea Stem Cells Sales Volume and Market Share by Application
6 Taiwan Stem Cells (Volume, Value and Sales Price)
6.1 Taiwan Stem Cells Sales and Value (2014-2019)
6.1.1 Taiwan Stem Cells Sales Volume and Growth Rate (2014-2019)
6.1.2 Taiwan Stem Cells Revenue and Growth Rate (2014-2019)
6.1.3 Taiwan Stem Cells Sales Price Trend (2014-2019)
6.2 Taiwan Stem Cells Sales Volume and Market Share by Type
6.3 Taiwan Stem Cells Sales Volume and Market Share by Application
7 India Stem Cells (Volume, Value and Sales Price)
7.1 India Stem Cells Sales and Value (2014-2019)
7.1.1 India Stem Cells Sales Volume and Growth Rate (2014-2019)
7.1.2 India Stem Cells Revenue and Growth Rate (2014-2019)
7.1.3 India Stem Cells Sales Price Trend (2014-2019)
7.2 India Stem Cells Sales Volume and Market Share by Type
7.3 India Stem Cells Sales Volume and Market Share by Application
8 Southeast Asia Stem Cells (Volume, Value and Sales Price)
8.1 Southeast Asia Stem Cells Sales and Value (2014-2019)
8.1.1 Southeast Asia Stem Cells Sales Volume and Growth Rate (2014-2019)
8.1.2 Southeast Asia Stem Cells Revenue and Growth Rate (2014-2019)
8.1.3 Southeast Asia Stem Cells Sales Price Trend (2014-2019)
8.2 Southeast Asia Stem Cells Sales Volume and Market Share by Type
8.3 Southeast Asia Stem Cells Sales Volume and Market Share by Application
9 Australia Stem Cells (Volume, Value and Sales Price)
9.1 Australia Stem Cells Sales and Value (2014-2019)
9.1.1 Australia Stem Cells Sales Volume and Growth Rate (2014-2019)
9.1.2 Australia Stem Cells Revenue and Growth Rate (2014-2019)
9.1.3 Australia Stem Cells Sales Price Trend (2014-2019)
9.2 Australia Stem Cells Sales Volume and Market Share by Type
9.3 Australia Stem Cells Sales Volume and Market Share by Application
10 Asia-Pacific Stem Cells Players/Suppliers Profiles and Sales Data
10.1 CCBC
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Stem Cells Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 CCBC Stem Cells Sales, Revenue, Price and Gross Margin (2014-2019)
10.1.4 Main Business/Business Overview
10.2 Vcanbio
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Stem Cells Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Vcanbio Stem Cells Sales, Revenue, Price and Gross Margin (2014-2019)
10.2.4 Main Business/Business Overview
10.3 Boyalife
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Stem Cells Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Boyalife Stem Cells Sales, Revenue, Price and Gross Margin (2014-2019)
10.3.4 Main Business/Business Overview
10.4 Beikebiotech
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Stem Cells Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Beikebiotech Stem Cells Sales, Revenue, Price and Gross Margin (2014-2019)
10.4.4 Main Business/Business Overview
...
11 Stem Cells Manufacturing Cost Analysis
11.1 Stem Cells Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Stem Cells
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Stem Cells Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Stem Cells Major Manufacturers in 2018
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change
15 Asia-Pacific Stem Cells Market Forecast (2019-2025)
15.1 Asia-Pacific Stem Cells Sales Volume, Revenue and Price Forecast (2019-2025)
15.1.1 Asia-Pacific Stem Cells Sales Volume and Growth Rate Forecast (2019-2025)
15.1.2 Asia-Pacific Stem Cells Revenue and Growth Rate Forecast (2019-2025)
15.1.3 Asia-Pacific Stem Cells Price and Trend Forecast (2019-2025)
15.2 Asia-Pacific Stem Cells Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2025)
15.2.1 Asia-Pacific Stem Cells Sales Volume and Growth Rate Forecast by Region (2019-2025)
15.2.2 Asia-Pacific Stem Cells Revenue and Growth Rate Forecast by Region (2019-2025)
15.2.3 China Stem Cells Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.4 Japan Stem Cells Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.5 South Korea Stem Cells Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.6 Taiwan Stem Cells Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.7 India Stem Cells Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.8 Southeast Asia Stem Cells Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.9 Australia Stem Cells Sales, Revenue and Growth Rate Forecast (2019-2025)
15.3 Asia-Pacific Stem Cells Sales, Revenue and Price Forecast by Type (2019-2025)
15.3.1 Asia-Pacific Stem Cells Sales Forecast by Type (2019-2025)
15.3.2 Asia-Pacific Stem Cells Revenue Forecast by Type (2019-2025)
15.3.3 Asia-Pacific Stem Cells Price Forecast by Type (2019-2025)
15.4 Asia-Pacific Stem Cells Sales Forecast by Application (2019-2025)
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer
